Australian Pharmaceutical Industries Archives - Inside FMCG

Priceline Pharmacy sales lift 2.4 per cent to $2.2 billion

API reports $4.0 billion in revenue for FY19 as flagship health and beauty retailer sees like-for-like sales return to growth.

API banks on its own “growth engines” after Sigma merger taken off the table

CEO Richard Vincent said API is no rush to sell its Sigma shares.

API offers $727m for Sigma Healthcare

Drug distributor plans to buy its rival in the face of increased competitive and regulatory pressures.

This week in FMCG

In the headlines this week.

Priceline owner flags record half-year

The group will soon have 462 stores.

API flags profit lift

Australian Pharmaceutical Industries expects to lift underlying profit despite a tough retail environment.

Latest Poll

NSW businesses: Do you expect the bushfire crisis and smoke haze to impact Christmas trading?